IHS FormWeb
Approved Formulary
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
IHS FormWeb
Approved Formulary
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Webpage Links
Restricted Medications Non-Formulary
×
Search results for:
ibandronate
ibandronate
Brand names:
Boniva
Form
Strength
TABLET, ORAL
150 mg
Display
Bone Resorption Inhibitors
Class:
922400
Medication comments:
Per policy, use of these medications is restricted as noted below:
View all
generic (Brand)
Restrictions
ibandronate (Boniva)
HB-SNF only, hold for inpatients
Enteral Drug Administration notes.
View all
Generic
(Brand)
Comments and Considerations
Recommendations for Administration with Enteral Nutrition
ibandronate
(
Boniva
)
Do NOT crush (mucosal irritant)
Do NOT administer through feeding tube.
Last updated:
Apr. 4, 2024
Restricted Medications
Non-Formulary
UpToDate
FDA DailyMed Package Insert
MedLinePlus (Patient Information)
MSDS Online
(Brand)
(Boniva)